Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy

Research output: Contribution to journal › Article › peer-review

Keywords

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9de1e4dd7fd94970b4cdb6c0306e7281,

title = "Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy",

keywords = "Male, Humans, Prostatic Neoplasms/drug therapy, Docetaxel, Hormones",

author = "C Oing and Bristow, {R G}",

year = "2023",

month = apr,

doi = "10.1016/j.esmoop.2023.101194",

language = "English",

volume = "8",

pages = "101194",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "ESMO Press",

number = "2",

}

TY - JOUR

T1 - Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy

AU - Oing, C

AU - Bristow, R G

PY - 2023/4

Y1 - 2023/4

KW - Male

KW - Humans

KW - Prostatic Neoplasms/drug therapy

KW - Docetaxel

KW - Hormones

U2 - 10.1016/j.esmoop.2023.101194

DO - 10.1016/j.esmoop.2023.101194

M3 - Article

C2 - 36947986

SN - 2059-7029

VL - 8

SP - 101194

JO - ESMO Open

JF - ESMO Open

IS - 2

ER -